Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04561817
Title To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements No
Sponsors Icahn School of Medicine at Mount Sinai

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer


Ipatasertib + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.